OVARIAN CLEAR CELL CARCINOMA
Clinical trials for OVARIAN CLEAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control rare ovarian cancer
Disease control Recruiting nowThis study tests whether combining two drugs, dostarlimab and LB-100, can help control ovarian clear cell carcinoma. About 21 adults with recurrent disease will receive the drugs by vein. The main goal is to check safety and see if the tumors shrink or stop growing.
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called Tulmimetostat (DZR123) in people with advanced solid tumors or lymphomas that have not improved with standard treatments. The drug is taken as a daily pill, either alone or combined with another drug (enzalutamide) for certain prostate…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug duo aims to outperform chemo in rare ovarian cancer
Disease control Recruiting nowThis phase 3 trial tests whether a new immunotherapy drug (QL1706) combined with bevacizumab can slow cancer growth better than standard chemotherapy in women with advanced ovarian clear cell carcinoma. About 226 participants will be randomly assigned to receive either the experi…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE3 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug aims to reactivate Cancer-Fighting genes in solid tumors
Disease control Recruiting nowThis phase 2 trial is testing valemetostat, a daily pill, in 900 adults with advanced solid tumors that have specific gene changes (like SMARCB1 or ARID1A). The drug works by blocking EZH1/2 enzymes to reactivate genes that normally protect against cancer. The main goal is to see…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cancer-Killing virus shows promise in tough ovarian cancer trial
Disease control Recruiting nowThis Phase 3 study tests whether a modified virus called Olvi-Vec, given with chemotherapy and bevacizumab, can help women with ovarian cancer that no longer responds to platinum drugs. About 186 participants will receive either the virus combination or standard chemotherapy. The…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC